MAIA Biotechnology (MAIA) Prepaid Assets (2021 - 2026)
MAIA Biotechnology (MAIA) posted quarterly Prepaid Assets of $902017.0 for Q1 2026, down 2.0% year-over-year from $920472.0 in Q1 2025, and down 13.59% quarter-over-quarter from $1.0 million in Q4 2025.
MAIA Biotechnology (MAIA) Prepaid Assets (2021 - 2026) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Prepaid Assets for 6 consecutive years, with $902017.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 2.0% year-over-year to $902017.0; the TTM figure through Mar 2026 stood at $902017.0 (down 2.0% YoY), while the FY2025 annual figure was $1.0 million, up 120.29% from the prior year.
- Prepaid Assets retreated to $902017.0 in Q1 2026 per MAIA's latest filing, from $1.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.0 million in Q4 2025 and bottomed at $243333.0 in Q2 2023.
- Historically, Prepaid Assets has averaged $535099.8 across 5 years, with a median of $467375.5 in 2022.
- Annual changes were most pronounced in 2022 — Prepaid Assets soared 916.41% — and 2023, when it slumped 51.53%.
- MAIA Biotechnology's Prepaid Assets stood at $554321.0 in 2022, then tumbled by 51.53% to $268677.0 in 2023, then surged by 76.36% to $473834.0 in 2024, then jumped by 120.29% to $1.0 million in 2025, then slipped by 13.59% to $902017.0 in 2026.
- Business Quant data shows MAIA's Prepaid Assets at $902017.0 in Q1 2026, $1.0 million in Q4 2025, and $780515.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | MAIA Biotechnology | 84.50 Mn | 56.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 641,540.00 |
| Mar 31, 2026 | 902,017.00 |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 780,515.00 |
| Jun 30, 2025 | 816,260.00 |
| Mar 31, 2025 | 920,472.00 |
| Dec 31, 2024 | 473,834.00 |
| Sep 30, 2024 | 495,650.00 |
| Jun 30, 2024 | 259,730.00 |
| Mar 31, 2024 | 272,583.00 |
| Dec 31, 2023 | 268,677.00 |
| Sep 30, 2023 | 414,120.00 |
| Jun 30, 2023 | 243,333.00 |
| Mar 31, 2023 | 398,874.00 |
| Dec 31, 2022 | 554,321.00 |
| Sep 30, 2022 | 460,917.00 |
| Jun 30, 2022 | 256,468.00 |
| Dec 31, 2021 | 54,537.00 |